Stock · NSE
ZYDUSLIFE
1,120.00▲ 12.30 (1.11%)Last 2 days · 15m candles25/8/2026, 00:35:38
Open: 1,109.20High: 1,120.00Low: 1,099.80Prev: 1,107.70
News mentioning ZYDUSLIFE
VERIFIEDET Finance·3d★ ON YOUR LIST
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injectionAI summary· POSITIVE
- ·Zydus Lifesciences has received final USFDA approval for its generic ascorbic acid injection.
- ·The injection is approved for the treatment of scurvy in specific patient groups.
- ·The USFDA designated this application as a Competitive Generic Therapy.
VERIFIEDET Finance·11d★ ON YOUR LIST
Delhi HC backs Zydus in trademark rowAI summary· POSITIVE
- ·The Delhi High Court upheld a ruling against Alder Biochem regarding the 'Biochem' trademark.
- ·Alder Biochem's argument that 'Biochem' is public property was dismissed by the court.
- ·Zydus Healthcare's registered trademark, held since 1959, is protected by this decision.
VERIFIEDET Markets·11d★ ON YOUR LIST
Lenskart Solutions among 7 stocks hitting 52-week highs; surge up to 20% in a monthAI summary· POSITIVE
- ·Seven BSE 200 stocks reached new 52-week highs on a day the Sensex increased by 113 points.
- ·Paytm saw the largest monthly increase at 19%.
- ·Other stocks reaching 52-week highs included Bosch, Lenskart Solutions, Aurobindo Pharma, Pidilite, Solar Industries India, and Zydus Lifesciences.
VERIFIEDET Stocks·11d★ ON YOUR LIST
Stocks to buy in 2026 for long term: Siemens, Zydus Lifesciences among 5 stocks that could give 10-20% returnAI summary· NEUTRAL
- ·Siemens and Zydus Lifesciences are among five stocks identified for potential 10-20% returns by 2026.
- ·The recommendations are based on insights from top brokerage firms and other sources.
- ·The article focuses on stocks suitable for long-term investment.
VERIFIEDET Stocks·12d★ ON YOUR LIST
Zydus Lifesciences shares drop 3% after Q1 earnings. Here's why Nuvama upgraded rating, hiked targetAI summary· NEGATIVE
- ·Zydus Lifesciences reported a 36% year-on-year drop in net profit for Q1.
- ·Operational revenue increased by nearly 22%, while expenses surged over 41%.
- ·Nuvama upgraded the stock to 'Buy' and raised its price target.
VERIFIEDET Markets·13d★ ON YOUR LIST
Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 croreAI summary· NEGATIVE
- ·Zydus Lifesciences reported a 36% year-on-year decline in net profit for Q1, reaching Rs 939.8 crore.
- ·Operational revenue increased by 22% to Rs 8,017 crore.
- ·EBITDA saw a 7.6% reduction compared to the previous year.
VERIFIEDET Stocks·13d★ ON YOUR LIST
Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 croreAI summary· NEGATIVE
- ·Zydus Lifesciences reported a 36% year-on-year decline in net profit for Q1, reaching Rs 939.8 crore.
- ·Operational revenue increased by 22% to Rs 8,017 crore.
- ·EBITDA saw a 7.6% reduction compared to the previous year.
VERIFIEDMint Markets·13d★ ON YOUR LIST
Q1 results 2026: RVNL to MRF among companies to declare Q1 results today; full list hereAI summary· NEUTRAL
- ·Rail Vikas Nigam, MRF, Zydus Lifesciences, NBCC (India), Senco Gold, and Manappuram Finance will report their Q1 FY27 results today.
- ·The companies are scheduled to declare their financial results for the first quarter of the fiscal year 2027.
- ·This list includes a diverse range of sectors within the Indian stock market.
VERIFIEDMint Markets·33d★ ON YOUR LIST
Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines importAI summary· NEGATIVE
- ·Several Indian pharmaceutical companies experienced a decline in their stock prices.
- ·Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma, and Zydus Lifesciences were among the top decliners.
- ·The decline occurred following a plan by Donald Trump regarding tariffs on generic medicine imports.
Google News, NIFTY/SENSEX·35d★ ON YOUR LIST
Nifty outlook: Buy the dips, says Angel One; prefers PTC Ind, Zydus Life - Business StandardVERIFIEDET Finance·44d★ ON YOUR LIST
Maharashtra FDA bars sale of two Cadila drugs over branding concernsAI summary· NEGATIVE
- ·Maharashtra FDA seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore.
- ·Sales of Aciloc 150 Plus and Aciloc 300 Plus were barred due to similar branding on different active ingredients.
- ·The action aims to prevent medication errors and safeguard public health.
VERIFIEDET Stocks·48d★ ON YOUR LIST
Sumitomo Chemical among 4 stocks that closed crossing below VWAPAI summary· NEGATIVE
- ·Four Nifty500 stocks, including Sumitomo Chemical India, closed over 1.5% below their VWAP on July 6.
- ·Zydus Wellness, Max Healthcare Institute, and Zensar Technologies were also among these stocks.
- ·This indicates potential bearish momentum and increased selling pressure.
VERIFIEDMint Companies·49d★ ON YOUR LIST
True North cashes out $2 billion for investors as PE firms step up exitsAI summary· POSITIVE
- ·True North has returned $2 billion to investors.
- ·This return is attributed to exits from several portfolio companies.
- ·Exited companies include FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness, and Home First Finance.
Google News, NIFTY/SENSEX·49d★ ON YOUR LIST
Nifty outlook: Buy the dips, says Angel One; likes IndusInd Bk, Zydus Life - Business StandardVERIFIEDET Finance·52d★ ON YOUR LIST
Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testAI summary· NEUTRAL
- ·Zydus Lifesciences has partnered with Apollo Hospitals to launch the Shield multi-cancer detection test in India.
- ·The blood test, developed with Guardant Health, can detect signals for multiple cancer types.
- ·The test is available for individuals aged 45 and above, aiming to improve early cancer detection.
Google News, NIFTY/SENSEX·52d★ ON YOUR LIST
HCL Tech, Zydus Life, Marico among buzzing stocks as SENSEX jumps over 500 pts, NIFTY50 up 0.8% in noon deals - UpstoxVERIFIEDET Markets·56d★ ON YOUR LIST
Market Trading Guide: Finolex Cables among 2 stock recommendations for TuesdayAI summary· POSITIVE
- ·Domestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal.
- ·Analysts recommend buying Finolex Cables.
- ·Analysts recommend buying Zydus Wellness, citing bullish technical setups, strong moving-average support and breakout patterns with upside potential.
VERIFIEDET Stocks·56d★ ON YOUR LIST
Market Trading Guide: Finolex Cables among 2 stock recommendations for TuesdayAI summary· POSITIVE
- ·Domestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal.
- ·Analysts recommend buying Finolex Cables.
- ·Analysts recommend buying Zydus Wellness, citing bullish technical setups, strong moving-average support and breakout patterns with upside potential.
VERIFIEDET Finance·59d★ ON YOUR LIST
Zydus, Sunshine to set up $20 million pharma JV in Sri LankaAI summary· POSITIVE
- ·Zydus Lifesciences and Sunshine Healthcare Lanka will form a $20 million joint venture.
- ·The new entity, Zydus Sunshine Lifesciences, will establish a manufacturing facility in Sri Lanka's Horana Export Processing Zone.
- ·The venture aims to increase local drug production and reduce import dependency.
VERIFIEDET Finance·62d★ ON YOUR LIST
Indian pharma firms gear up to supply key cancer drug to USAI summary· NEUTRAL
- ·Indian drugmakers are preparing to supply ifosfamide injection to the US.
- ·Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to provide the chemotherapy drug.
- ·The US FDA has contacted Indian pharmaceutical bodies to find manufacturers for the drug.
Google News, India stocks·68d★ ON YOUR LIST
Zydus Completes Major Overseas Acquisition Deal | Jaiprakash Associates to be Delisted from Stock Exchanges | Top Buzzing Stocks Today - EquitymasterVERIFIEDET Stocks·68d★ ON YOUR LIST
Zydus Lifesciences shares in focus as firm acquires US-based Assertio Holdings for $166 millionVERIFIEDET Finance·69d★ ON YOUR LIST
Zydus Lifesciences completes acquisition of AssertioAI summary· NEUTRAL
- ·Zydus Lifesciences has completed the acquisition of Assertio Holdings Inc.
- ·The acquisition was made through its wholly-owned subsidiary, Zara Merger Sub Inc.
- ·The transaction involved a cash tender offer for all outstanding shares of Assertio's common stock.
VERIFIEDET Stocks·75d★ ON YOUR LIST
Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a monthVERIFIEDET Markets·75d★ ON YOUR LIST
Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a monthVERIFIEDET Stocks·75d★ ON YOUR LIST
Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?VERIFIEDET Markets·75d★ ON YOUR LIST
Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?VERIFIEDET Finance·82d★ ON YOUR LIST
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsAI summary· NEUTRAL
- ·The Delhi High Court has directed the CDSCO to review a petition against Zydus Lifesciences' semaglutide injection approval.
- ·A diabetes patient has raised concerns regarding the drug's delivery system, citing potential health risks.
- ·The CDSCO is required to make a decision on the patient's representation within two months.
VERIFIEDMint Markets·83d★ ON YOUR LIST
Zydus Lifesciences share buyback to open on 4 June: Should you participate or not?AI summary· NEUTRAL
- ·Zydus Lifesciences share buyback is set to open on June 4.
- ·The company's stock was trading 2.5% lower at ₹1,063 per share on June 2.
- ·Experts are offering opinions on retail investor participation in the buyback.
VERIFIEDMint Markets·87d★ ON YOUR LIST
Stocks to watch: Zydus Life, IndiGo, RIL among 10 shares in focus today; check list hereAI summary· NEUTRAL
- ·The Sensex declined 142 points, or 0.19%, to close at 75,867.80 on Wednesday.
- ·The Nifty 50 slipped 7 points, or 0.03%, to settle at 23,907.15.
- ·Zydus Life, IndiGo, and RIL are among 10 shares in focus for May 29.